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Consumers of fresh dairy products and consumers of cheese exhibit different dietary patterns
Vanina Bongard (1), Jean Ferrières (2), Pascale Hebel (3), Justine Colin (3), Jean-Michel Lecerf (4) (1) CHU Toulouse, Epidémiologie, Toulouse, France -(2) CHU Toulouse, Cardiologie, Toulouse, France -(3) CREDOC, Paris, France -(4) Institut Pasteur, Lille, France Background: Recommendations for healthy food choice emphasize the consumption of 2 to 3 servings of dairy products per day. We aimed to describe dietary patterns and adherence to recommendations according to the consumption of different types of dairy products.
Methods: Data from the 2010 CCAF (Comportements et Consommations Alimentaires en France) cross-sectional survey with 7-day food record were analysed. Fresh Dairy Products (FDP) included all fresh dairy except dairy desserts and Greek yogurts. Cheese included all cheese except cottage cheese. The PANdiet (Probability of Adequate Nutrient intake) score was used to assess adherence to dietary recommendations.
Results:
The sample comprised 948 French adults from the general population, 22% consumed no FDP and 30% were low FDP consumers (1 to 3 servings/week), 9% consumed no cheese and 37% were low cheese consumers (1 serving/day). Compared to low consumers, high FDP and cheese consumers were characterized by significantly (p<0.05) higher intakes of fruits and vegetables. High FDP consumers also exhibited significantly higher intakes of simple sugars (+25%) than low FDP consumers, and significantly lower intakes of pastas (-27%), ready-to-eat meals (-16%), and alcoholic beverages (-22%). No significant difference was observed for daily energy intake, total fat, saturated fat, or sodium. On the other hand, high cheese consumers exhibited significantly higher daily energy intake (+23%) and higher consumptions of alcohol (+96%), total fat (+31%), saturated fat (+41%) and sodium (+36%), compared to low consumers, with no difference for simple sugar intake. The PANdiet score was significantly better among high FDP consumers than among low, but significantly worse among high cheese consumers than among low.
Conclusion:
Consumers of FDP and consumers of cheese adopt different dietary patterns with varying intakes of sugars, fats, and sodium. Adherence to dietary recommendations is better among high FDP consumers.
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Impact of low sodium diet on health-related quality of life in heart failure patients: development and first validation results of a new burden scale
Etienne Audureau (1), Aline Ferreira Alexandre (1), Florence Canouï Poitrine (1), Veronique Benedyga (2), Nathalie Goncalves (2), Hélène Duchossoir (2), Annick Léger (2), Charles Taieb (3), Thibaud Damy (4) (1) CHU Henri Mondor-APHP, Santé publique, Créteil, France -(2) CHU Henri Mondor-APHP, Diététique, Créteil, France -(3) Laboratoires Pierre Fabre, Paris, France -(4) CHU Henri Mondor-APHP, Cardiologie, Créteil, France Background: Quality of life (QoL) and burden scales have proved to be useful in estimating the impact of diseases and treatments from the patient's perspective. Yet, no data nor scales are currently available with respect to the burden associated with the low sodium diet usually prescribed in heart failure (HF) patients, despite the lack of evidence of its efficacy and the previously reported evidence for negative effects in restricted diets (e.g. gluten-free).
Objectives:
To develop and validate a low sodium diet burden scale in HF patients.
Methods: After a literature review and interviews with patients, 14 items were selected (coded 0-4, global score/70, higher scores reflecting higher burden) for the following domains relating to dietary habits: organization, pleasure, leisure, social life, vitality and self-rated health. The validation study was conducted in HF patients (NYHA I-IV) prospectively enrolled between 09/2012-09/2013 (H.Mondor Hospital, Cardiology Dpt, Creteil).
Results: 93 patients completed the burden scale (men 64%; mean age 63.2 [±13.3]), of whom 14% had a highly restricted low sodium diet (<3g/d), 37% moderately restricted (3-6g) and 49% mildly restricted. Median burden score was 9 (IQR 3-17; min 0-max 40); results showed an excellent acceptability of the scale (non response rates/item: 2% to 12%), excellent internal consistency (Cronbach α=0.90; Spearman correlation coefficients between items and global score: r s from 0.47 [appetite] to 0.81 [mental burden]; p<0.001), good convergent validity (positive correlation between the global burden score and dimensions scores from the QoL Minnesota scale: r s =0.49 [physical dimension], 0.57 [mental], 0.52 [global]; p<0.001) and good discriminative capacity of the patients with a highly restricted diet (p=0.01; Figure next page).
Conclusion:
These first findings demonstrate the good psychometric properties of a new burden scale and show that highly restricted salt diet is associated with high burden in HF patients. (2015) 7, 87-90 0526 Predictive factors for obtaining a correct therapeutic range using antivitamins K: a tertiary center experience Ruxandra Jurcut (1), Ciprian Jurcut (2), Sebastian Militaru (1), Oliviana Geavlete (1), Nic Dragotoi (1), Ana Maria Daraban (1), Sergiu Sipos (1), Carmen Ginghina (1) (1) Institut de Maladies Cardiovasculaires, Cardiologie, Bucarest, Roumanie -(2) Central University Emergency Military Hospital, Bucarest, Roumanie Background: Patient adherence is an essential factor in obtaining an efficient oral anticoagulation using antivitamin K drugs (AVK), a situation with a narrow therapeutic window. Therefore patient education and awareness are crucial for a good management and should be based on a correct estimation of the current situation.
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Material and methods: This study included 67 hospitalized chronically anticoagulated patients (pts) (mean age: 62.6±13.1 years; men 45.6%) who responded to a 25-items questionnaire to assess their knowledge on AVK therapy management. Laboratory and clinical data were used to determine INR value at admission, as well as to calculate CHADS2-VASC and HAS-BLED scores for patients with atrial fibrillation (AF).
Results:
The majority of pts (61.8%) were receiving AVK for AF, the others having a mechanical prosthesis and previous thromboembolic disease or stroke. In the AF group, mean CHADS2-VASC score was 3.1±1.5, while average HAS-BLED score was 1.8±1.2. More than half of all pts (52.9%) had at admission an INR outside of the therapeutic range, with the majority (42.1%) having a low INR. A correct INR value was predicted by the education level (higher education), the diagnostic indication (pts with mechanical prosthesis being best managed), and the concomitant use of other antithrombotic therapies. Pts presenting with a therapeutic INR had a trend towards longer treatment duration than those outside the therapeutic range (62±72 vs 36±35 months, p=0.06). There was no correlation between admission INR and pts living conditions, INR monitoring frequency, bleeding history.
Conclusions:
In a tertiary cardiology center, more than half pts receiving AVK are admitted with an INR outside the therapeutic range. Pts with mechanic prosthesis and complex antithrombotic regimens appear as most careful with INR monitoring. Identifying pts groups with lowest therapeutic range rate could help attending physicians educate pts focusing on specific awareness issues.
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CHA2DS2-VASc score is a predictor of stroke and death in patients with atrial flutter Purpose: The CHA 2 DS 2 -VASc score has been validated to stratify the risk of thromboembolism and accurately predicts the risk of stroke in patient with non-valvular atrial fibrillation. We sought to investigate how accurately this score predicts the risk of stroke and death in patients with atrial flutter.
Methods: Between July 1998 and December 2011, 197 consecutive patients, hospitalised for atrial flutter, were enrolled in the cohort. All patients were followed-up at least 6 months and cardiovascular events recorded. The endpoint was defined as the first occurrence of stroke or death. The Cox analysis was adjusted on warfarin, antiplatelet and antiarrhythmic treatments at discharge.
Results:
Mean age was 67±13 years and 152 (77%) were men. At baseline, 92 patients (47%) had hypertension, 33 (17%) diabetes, and 10 (5%) had a history of stroke or thromboembolism. CHA 2 DS 2 -VASc score was = 0 in 26 (13%), = 1 in 36 (18%), and ≥2 in 135 (69%) patients. Seventy-seven events occurred during a mean follow-up of 4.7±3.7 years. As shown in the Kaplan Meier curves (figure) patients with a CHA 2 DS 2 -VASc score ≥2 were at higher risk of stroke or death. The adjusted Cox model showed that a CHA 2 DS 2 -VASc score ≥2 was a predictor of risk of stroke or death with a hazard ratio of 2.17 (95%CI 1.21-3.90, p=0.009).
